<?xml version="1.0" encoding="UTF-8"?>
<ref id="R38">
 <label>38</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Hoogeveen</surname>
    <given-names>RC</given-names>
   </name>, 
   <name name-style="western">
    <surname>Boonstra</surname>
    <given-names>A</given-names>
   </name>
  </person-group>
  <article-title>Checkpoint inhibitors and therapeutic vaccines for the treatment of chronic HBV infection</article-title>. 
  <source>Front Immunol</source>
  <year>2020</year>;
  <volume>11</volume>:
  <elocation-id>401</elocation-id>. 
  <pub-id pub-id-type="doi">10.3389/fimmu.2020.00401</pub-id>
  <?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/32194573?>
  <pub-id pub-id-type="pmid">32194573</pub-id>
 </mixed-citation>
</ref>
